Docenz Injektionsvätska, suspension, förfylld spruta

País: Suécia

Língua: sueco

Origem: Läkemedelsverket (Medical Products Agency)

Ingredientes ativos:

influensavirus A/New Caledonia/20/99 (H1N1)-liknande stam (A/New Caledonia/20/99 (IVR-116)), ytantigen, inaktiverat; influensavirus B/Hong Kong/330/2001-liknande stam (B/Shangdong/7/79), spjälkat virus, inaktiverat; influesavirus A/Moscow/10/99(H3N2)-liknande stam (A/Panama/2007/99 (RESVIR-17)), ytantigen, inaktiverat

Disponível em:

Mimer Medical

Código ATC:

J07BB02

DCI (Denominação Comum Internacional):

influenza virus (A/New Caledonia/20/99 (H1N1)-like strain (A/New Caledonia/20/99 (IVR-116)), surface antigen, inactivated; influenza virus B/Hong-Kong -/330/2001- like strain (B/Shangdong/7/79), spjälkat virus, inactivated; influesavirus A/Moscow/10/99(H3N2)-like strain (A/Panama/2007/99 (RESVIR-17)), surface antigen, inactivated

Forma farmacêutica:

Injektionsvätska, suspension, förfylld spruta

Composição:

influensavirus B/Hong Kong/330/2001-liknande stam (B/Shangdong/7/79), spjälkat virus, inaktiverat 15 mikrog Aktiv substans; influesavirus A/Moscow/10/99(H3N2)-liknande stam (A/Panama/2007/99 (RESVIR-17)), ytantigen, inaktiverat 15 mikrog Aktiv substans; influensavirus A/New Caledonia/20/99 (H1N1)-liknande stam (A/New Caledonia/20/99 (IVR-116)), ytantigen, inaktiverat 15 mikrog Aktiv substans

Tipo de prescrição:

Receptbelagt

Área terapêutica:

spjälkat virus eller ytantigen

Status de autorização:

Avregistrerad

Data de autorização:

2004-10-29